<DOC>
	<DOCNO>NCT01213173</DOCNO>
	<brief_summary>The purpose study evaluate effect Succinate Metoprolol ( Betaloc ZOK® ) ( 95 - 190 mg ) heart rate Stable angina patient .</brief_summary>
	<brief_title>Evaluation Succinate Metoprolol Heart Rate Stable Angina Patients</brief_title>
	<detailed_description />
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Provision inform consent prior study specific procedure Chinese patient Heart rate ≥ 65bpm Has diagnose Stable angina least 1 month stable angina pectoris symptom within 2 week previous enrolment ( Please find diagnose criterion Stable angina Appendix C ) With Left ventricular ejection fraction ≥ 50 % accord ultrasound cardiogram ; Has betablockers least 4 weeks* , dose equivalent Betaloc ZOK® 23.7547.5mg/day . Acute myocardial infarction within 6 month Unstable angina Prinzmetal 's angina II degree AV block great Significant clinical , laboratory electrocardiographic abnormality would place subject undue risk ( Investigator 's opinion ) include : Significant renal impairment ( serum creatinine &gt; 2.0 mg/dL ) Serum Alanine Aminotransferase Aspartate Aminotransferase &gt; 3 x upper limit reference range Serum potassium &lt; 3.0 mEq/L Serum sodium ≤ 130 mEq/L Acute chronic hepatitis cirrhosis ( clinical diagnosis ) Uncontrolled hyperthyroidism ( clinical diagnosis ) Systolic blood pressure ≥ 180 mmHg , &lt; 100mmHg enrolment Patients unstable , compensated heart failure ( pulmonary oedema , hypoperfusion hypotension )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>angina pectoris</keyword>
	<keyword>chest pain</keyword>
	<keyword>heart rate</keyword>
</DOC>